TRT and Cognitive Function: Does Testosterone Help Brain Fog? (2026 Guide)

Executive Summary

Brain fog is among the most frustrating and life-disrupting symptoms men with low testosterone report — the inability to concentrate at work, the word-retrieval failures, the sense that mental processing has slowed. It is also one of the hardest symptoms to attribute definitively to testosterone, because the same cognitive complaints arise from sleep deprivation, thyroid dysfunction, depression, cardiovascular disease, vitamin deficiencies, and normal aging. Most brain fog in men over 35 has multiple contributing causes, and testosterone is rarely the only one.

What the research does show clearly is that testosterone plays a direct biological role in brain function — androgen receptors are densely expressed in the hippocampus (the brain's primary memory center) and prefrontal cortex (executive function, working memory, concentration). Low testosterone is associated with measurable declines in specific cognitive domains, particularly verbal memory, working memory, and processing speed. The question is whether TRT reliably reverses these deficits, and for which men.

The answer from the highest-quality trials is: modest and variable. The T-Trials cognitive sub-study found no benefit on memory in older men with age-associated memory impairment. More recent meta-analyses and real-world data are more encouraging, particularly for younger men with confirmed clinical hypogonadism. This guide lays out the full picture — the mechanisms, the evidence, the confounders, and a practical framework for evaluating whether your own brain fog has a hormonal component. For the full side-effect landscape, see TRT side effects. For sleep, which is tightly coupled to both testosterone and cognition, see TRT and sleep.

At-a-Glance Comparison

How testosterone levels and TRT interact with specific cognitive domains. Evidence quality and effect size vary significantly by domain, study population age, and severity of testosterone deficiency. Updated March 2026.

How testosterone affects brain function — the biological mechanisms

Testosterone's role in cognition is not a speculation — it is supported by a well-characterized set of neurobiological mechanisms. Understanding these mechanisms helps explain both why low testosterone causes cognitive symptoms and why TRT produces variable results depending on population and timing. Buyers searching for testosterone and brain fog usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Androgen receptors are densely expressed throughout the brain, with the highest concentrations in the hippocampus (the primary memory-encoding center), the prefrontal cortex (executive function, working memory, concentration), and the amygdala (emotional processing and threat response). Testosterone acts at these receptors both directly through androgen receptor pathways and indirectly through conversion to estradiol, which then acts on estrogen receptors that are also broadly expressed in the brain — including the hippocampus and cortex. Several specific mechanisms are well-documented. First, testosterone promotes neurogenesis — the growth of new neurons — particularly in the hippocampal dentate gyrus, the region most important for encoding new memories. Adult hippocampal neurogenesis declines with age and is further suppressed by testosterone deficiency. Second, testosterone supports BDNF (brain-derived neurotrophic factor) expression, a critical protein for neuronal survival, synaptic plasticity, and learning consolidation. Low T is associated with reduced BDNF in multiple studies. Third, testosterone modulates cholinergic neurotransmission — the acetylcholine system that is central to memory function and is disrupted in Alzheimer's disease. Hypogonadism is associated with reduced acetylcholine synthesis and receptor density in memory circuits. Fourth, testosterone has direct neuroprotective effects against oxidative stress, amyloid toxicity, and inflammation — mechanisms that are relevant both to normal cognitive aging and to neurodegenerative disease risk. Finally, testosterone's effects on sleep architecture (particularly slow-wave sleep and REM sleep, which are essential for memory consolidation) mean that low T indirectly impairs cognition through sleep disruption — a pathway that is often more clinically significant than the direct hormonal effects. For the sleep connection in detail, see TRT and sleep. For how mood interacts with cognition, see TRT and anxiety. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: interpreting the biological plausibility of testosterone's role in cognition as evidence that TRT will definitively cure brain fog. The mechanisms exist, but the clinical trials show variable, often modest, effect sizes — particularly in older populations. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

What the T-Trials cognitive sub-study actually found — and why it is often misread

The T-Trials cognitive sub-study is the largest and most rigorous randomized controlled trial of testosterone and cognition ever conducted. Its results are frequently cited — and frequently misapplied — in discussions about TRT and brain fog. Buyers searching for testosterone and brain fog usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The Testosterone Trials (T-Trials) were a coordinated set of seven placebo-controlled RCTs funded by the NIH, enrolling 788 men aged 65 or older with low testosterone (below 275 ng/dL) and confirmed age-associated memory impairment (AAMI). The cognitive sub-study, led by Resnick et al. and published in JAMA in 2017, randomized men to testosterone gel or placebo for 12 months and measured outcomes across multiple cognitive domains including verbal memory, visual memory, spatial function, and executive function. The finding: TRT did not significantly improve memory or any cognitive domain in this population. This is the finding that most critics cite when arguing TRT does not help brain fog. But the T-Trials cognitive sub-study has important population limitations that are often overlooked. The study enrolled men aged 65+, the majority of whom had age-associated memory impairment — a condition caused primarily by normal aging processes, not testosterone deficiency. For most of these men, low T was an additional comorbidity, not the primary driver of their cognitive decline. The study specifically excluded men under 65, men without AAMI at baseline, and men in the prime-of-life 35–55 range who represent the majority of online TRT patients. In contrast, studies in younger men with confirmed clinical hypogonadism — not age-associated memory impairment — have shown more encouraging results. Multiple meta-analyses including Beauchet 2006, Sherwin 2012, and Cherrier et al. 2019 found consistent modest improvements in verbal memory and spatial cognition in men with confirmed pathological testosterone deficiency. A 2019 systematic review in the Journal of the Endocrine Society found TRT produced improvements in spatial cognition (consistent across studies) and verbal memory (significant in younger, more severely hypogonadal men). The TRAVERSE trial (2023), the largest TRT safety trial ever conducted, did not include pre-specified cognitive endpoints, but patient-reported outcomes data from TRAVERSE suggest meaningful improvements in vitality and cognitive clarity in the primary trial population (men aged 45–80 with cardiovascular risk and confirmed hypogonadism). For the full TRAVERSE cardiovascular data, see TRT and cardiovascular health. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: citing the T-Trials cognitive sub-study as proof that 'TRT doesn't help brain fog' without specifying that the study tested a population of elderly men with age-associated memory impairment — a different population than most prime-of-life TRT patients. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

When brain fog IS due to low testosterone — the profile that responds

Not every man with brain fog and low testosterone will see cognitive improvement on TRT. Understanding which men are most likely to respond helps set realistic expectations and identify the best candidates. Buyers searching for testosterone and brain fog usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The clinical profile most likely to see meaningful cognitive improvement on TRT shares several characteristics. First, earlier onset hypogonadism: men who developed testosterone deficiency in their 30s or 40s (rather than as a consequence of normal aging in their 60s+) are more likely to see cognitive recovery. The hippocampus and prefrontal cortex have greater neuroplasticity earlier in life, and the cognitive deficits may be more directly attributable to testosterone deficiency rather than aging. Second, severe hypogonadism with clear cognitive onset correlation: men who can identify a point in time when their mental sharpness declined alongside the onset of other low-T symptoms — reduced libido, muscle loss, fatigue, body fat gain — rather than a gradual, decades-long cognitive aging process. Third, secondary hypogonadism: men with HPG axis suppression (confirmed by low LH and FSH alongside low testosterone) who have not yet developed primary testicular failure often see more robust symptom recovery because the underlying testosterone production machinery is intact. Fourth, baseline sleep treatment: men who have already addressed sleep disorders (particularly obstructive sleep apnea, which is highly prevalent in men with low T) before or alongside TRT show more complete cognitive improvement — because much of the cognitive benefit of TRT in these men comes from the sleep improvement TRT enables, rather than direct brain effects. Fifth, resolution of mood symptoms: depression and anxiety produce significant cognitive impairment independently of testosterone. Men who achieve mood improvement from TRT often report substantial improvements in concentration and clarity as a downstream effect — even when direct testosterone → cognition pathways are only modestly activated. For the sleep-T relationship, see TRT and sleep. For primary vs secondary hypogonadism evaluation, see primary vs secondary hypogonadism. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: men expecting dramatic cognitive transformation from TRT when their brain fog is driven primarily by sleep deprivation, depression, or age-related processes that testosterone cannot reverse. The cognitive benefit of TRT exists, but it is not a nootropic or a cognitive enhancer — it is a restoration of deficits caused by hormone deficiency. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

The major confounders — other causes of brain fog that TRT will not fix

Brain fog is a symptom, not a diagnosis. Before attributing cognitive complaints to testosterone deficiency, a responsible evaluation rules out the other common and treatable causes — several of which are as prevalent as hypogonadism in the TRT-seeking demographic. Buyers searching for testosterone and brain fog usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

The most clinically significant confounders of brain fog in men pursuing TRT are: Sleep deprivation and sleep disorders. Obstructive sleep apnea (OSA) is significantly more prevalent in men with low testosterone — both because low T contributes to OSA and because OSA suppresses testosterone production. Men with untreated OSA have cognitive impairment that is often severe and significantly exceeds that attributable to testosterone alone. CPAP treatment typically produces dramatic cognitive improvement within weeks. If you snore, wake unrefreshed, or experience daytime sleepiness, a sleep study should precede TRT evaluation. Thyroid dysfunction. Hypothyroidism produces cognitive symptoms that are nearly identical to low-T brain fog: mental sluggishness, concentration problems, word-finding difficulty, memory complaints, fatigue. TSH and free T4 should be part of any comprehensive brain fog evaluation. Depression and anxiety. Cognitive impairment is a cardinal feature of both conditions. Concentration deficits, working memory problems, and processing speed reduction are well-documented neurological consequences of depression — not just subjective complaints. Men who treat depression (through therapy, medication, or both) often find brain fog resolves without any testosterone intervention. Vitamin and micronutrient deficiencies. Vitamin B12 deficiency produces neurological symptoms including cognitive impairment, particularly in men with dietary restrictions or on metformin (which depletes B12). Vitamin D deficiency, highly prevalent in men with low T, is also associated with cognitive performance. Iron deficiency can cause fatigue and cognitive impairment. Cardiovascular risk. Cerebrovascular insufficiency — from hypertension, metabolic syndrome, or early atherosclerosis — reduces cognitive blood flow. Men with significant cardiovascular risk factors who are also hypogonadal may have cognitive impairment driven more by vascular factors than hormonal ones. Testosterone treatment addresses one of these, but cannot repair vascular damage. Estradiol imbalance on TRT. Men already on TRT who develop brain fog should check estradiol levels. Both high E2 (causing cognitive fog via receptor-level overactivation) and low E2 (from over-suppression with aromatase inhibitors) can impair cognition. Estradiol is essential for optimal brain function — suppressing it to near-zero is a common and underrecognized cause of cognitive deterioration on TRT. See anastrozole on TRT for the full estradiol management guide. For lab evaluation, see how to read testosterone lab results and TRT monitoring guide. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: starting TRT for brain fog that is primarily caused by sleep apnea, hypothyroidism, B12 deficiency, or depression. These conditions can produce testosterone-level changes as a downstream effect, making the lab findings look like primary hypogonadism when the actual drivers are elsewhere. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

What TRT realistically does for cognition — timeline and effect sizes

Men starting TRT often want to know: how much better will my thinking get, and how fast? Setting honest expectations based on the actual evidence protects against both disappointment and dose-chasing. Buyers searching for testosterone and brain fog usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Based on the combined evidence, the most realistic picture of TRT's cognitive effects is as follows. Subjective brain fog improvement is among the most consistently reported early TRT benefits. Patient-reported outcomes across multiple studies and clinical databases show that men commonly notice improved mental clarity, concentration, and word retrieval within 4–8 weeks of stable testosterone levels. The magnitude of subjective improvement is typically moderate — not the dramatic cognitive transformation described in some marketing — but meaningful and reproducible. The subjective improvement often reflects TRT's combined effects on sleep quality, mood, motivation, and energy, in addition to any direct cognitive effects. Verbal memory and working memory show modest measurable improvements in studies of younger, more severely hypogonadal men, with effect sizes in the small-to-moderate range (d=0.2–0.4). This translates to real-world improvements — faster word recall, better ability to hold information in mind during complex tasks — but not a dramatic transformation of baseline cognitive capacity. Full cognitive effects take 3–6 months to develop, consistent with the time required for neurobiological changes (BDNF expression, hippocampal neurogenesis, synaptic remodeling) to reach functional significance. Spatial cognition shows the most consistent and reproducible TRT benefit in the literature — men who notice improvements in navigation, spatial reasoning, or visual-spatial tasks are seeing the most directly hormone-sensitive cognitive domain. Executive function improvements are largely indirect — mediated through TRT's effects on mood, motivation, and sleep rather than direct prefrontal cortex effects. Men who see mood and energy improvement on TRT often report substantially better executive function without any measurable change on formal cognitive testing. Age-related memory impairment in men over 65 is unlikely to respond significantly to TRT based on the T-Trials data — the processes driving memory loss in this population extend well beyond testosterone deficiency. For the full TRT timeline across all symptoms, see how long TRT takes to work. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: dose-chasing for cognitive benefits that plateau or fail to materialize. Some men, particularly those whose brain fog is not hormone-driven, pursue progressively higher testosterone doses seeking cognitive enhancement beyond what TRT can deliver — exposing themselves to side effect risk without meaningful cognitive gain. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Practical decision framework: is your brain fog hormone-related?

Rather than guessing whether testosterone is driving your cognitive symptoms, a structured evaluation framework can clarify the probability before treatment decisions are made. Buyers searching for testosterone and brain fog usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Work through the following five factors to evaluate whether your brain fog has a meaningful hormonal component. Factor 1: Onset correlation. Did brain fog, concentration problems, or word-retrieval difficulty worsen alongside other classic low-T symptoms — reduced libido, reduced morning erections, muscle loss, increased belly fat, fatigue, reduced exercise recovery? A symptom cluster that emerged together within the same 1–2 year window strongly suggests a hormonal contribution. Brain fog that has been present since adolescence, that predates other low-T symptoms, or that has not changed alongside physical symptoms is less likely to be primarily hormonal. Factor 2: Lab confirmation. Total testosterone below 300 ng/dL (or below 350 ng/dL in symptomatic men, per some AUA guidelines) with consistent symptoms is the diagnostic threshold for clinical hypogonadism. Free testosterone below the lab reference range despite borderline total T (due to elevated SHBG) can indicate clinically significant deficiency even with a normal-appearing total. LH and FSH evaluation tells you whether hypogonadism is primary or secondary — relevant because secondary hypogonadism (low LH/FSH with low T) may be more amenable to enclomiphene or lifestyle optimization before TRT. Factor 3: Sleep status. If you have untreated obstructive sleep apnea, inadequate sleep hours (under 7 per night consistently), or poor sleep quality, address this before attributing brain fog to testosterone. The cognitive damage from sleep deprivation reliably exceeds that from most cases of mild-moderate testosterone deficiency. Factor 4: Thyroid and metabolic evaluation. A TSH outside the normal range, vitamin B12 below 400 pg/mL, or fasting glucose above 100 mg/dL are each individually capable of producing the brain fog syndrome — and each should be investigated before and alongside testosterone evaluation. Factor 5: Response trial. If TRT is started and cognitive symptoms show meaningful subjective improvement within 8–12 weeks of stable levels — not just a first-week placebo response, but a sustained, reproducible improvement — this is your best evidence that the hormonal component was real and significant. If cognitive symptoms fail to improve by 12 weeks with confirmed stable levels, the primary drivers of brain fog are likely outside the hormonal domain. For comprehensive provider comparison including labs management, see compare TRT providers. For the complete TRT protocol picture, see TRT protocol complete guide. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: premature attribution of brain fog to testosterone without completing the differential evaluation. Starting TRT for brain fog that is driven by undiagnosed sleep apnea, hypothyroidism, or depression produces two outcomes: the hormone doesn't work for the stated goal, and the actual condition continues to progress untreated. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

If brain fog and concentration problems are driving your interest in TRT, the most important step is a comprehensive evaluation — not just a testosterone number, but a full differential including sleep, thyroid, and metabolic health. Use our provider comparison tool to find clinics that order complete diagnostic panels and take a measured, symptom-first approach to treatment decisions.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

Can low testosterone cause brain fog?

Yes. Low testosterone is associated with reduced performance in verbal memory, working memory, spatial cognition, and processing speed. The mechanisms are well-characterized: testosterone acts through androgen receptors densely expressed in the hippocampus and prefrontal cortex, supports BDNF (a key neuroprotective protein), promotes hippocampal neurogenesis, and modulates the cholinergic neurotransmission system central to memory function. Additionally, low T disrupts sleep architecture, and sleep deprivation independently causes severe cognitive impairment.

Does TRT improve cognitive function and brain fog?

TRT produces modest to moderate improvements in subjective brain fog, spatial cognition, and working memory in men with confirmed clinical hypogonadism — particularly in men under 65 with symptomatic testosterone deficiency. The T-Trials cognitive sub-study found no benefit in men over 65 with age-associated memory impairment, but this population differs significantly from the typical prime-of-life TRT patient. Subjective improvement in mental clarity and concentration is one of the most consistently reported early TRT benefits.

How long does it take for TRT to improve brain fog?

Most men report subjective improvement in mental clarity and concentration within 4–8 weeks of stable testosterone levels. Full cognitive effects — particularly neurobiological changes like hippocampal neurogenesis and BDNF expression — take 3–6 months to develop. If cognitive function has not meaningfully improved by 12 weeks of confirmed stable testosterone levels, the primary drivers of brain fog are likely outside the hormonal domain.

What does the T-Trials cognitive study show?

The T-Trials cognitive sub-study (Resnick et al. 2017, JAMA) found that TRT did not significantly improve memory or cognitive function in men aged 65+ with age-associated memory impairment over 12 months. However, this result applies to elderly men with age-related cognitive decline — not to younger men (35–55) with confirmed pathological hypogonadism. Meta-analyses of studies in younger, more severely hypogonadal men show more encouraging results, particularly for spatial cognition and verbal memory.

What are the other causes of brain fog I should rule out first?

Before attributing brain fog to testosterone, a responsible evaluation rules out: obstructive sleep apnea (extremely common in men with low T, and often a more significant cognitive driver), hypothyroidism (TSH), vitamin B12 deficiency, vitamin D deficiency, iron deficiency, depression and anxiety disorders, diabetes and metabolic syndrome, and cardiovascular risk factors that reduce cerebral blood flow. Each of these conditions can produce brain fog symptoms that are indistinguishable from low-T cognitive complaints on history alone.

Can estrogen levels affect cognitive function on TRT?

Yes — and this is a commonly overlooked cause of brain fog developing after starting TRT. Both elevated estradiol (from aromatization) and over-suppressed estradiol (from excessive aromatase inhibitor use) can impair cognitive function. Estrogen receptors are broadly expressed in the brain, including in the hippocampus, and optimal E2 is required for normal brain function. Men who develop or worsen brain fog after starting TRT should have estradiol checked before making any other protocol changes.

Does brain fog mean I have low testosterone?

Not necessarily. Brain fog is a nonspecific symptom with many possible causes — low T is one of them, but sleep deprivation, thyroid dysfunction, B12 deficiency, depression, anxiety, metabolic syndrome, and cardiovascular disease are equally or more common causes in men who present with cognitive complaints. A structured differential evaluation, including a full hormonal and metabolic panel, is necessary to determine whether testosterone is a significant driver.

What cognitive domains does TRT help most?

The strongest and most consistent TRT cognitive benefit across studies is in spatial cognition — visuospatial reasoning and navigation. Working memory and verbal fluency show modest improvements in younger hypogonadal men. Processing speed improvements are variable. Executive function improvements are largely indirect, mediated through TRT's positive effects on mood, motivation, and sleep. Subjective overall cognitive clarity improvement is among the most consistently reported patient-reported outcomes, though it is difficult to attribute entirely to direct cognitive effects vs. mood and sleep improvements.

Is enclomiphene better than TRT for cognitive symptoms?

For men with secondary hypogonadism (low LH/FSH alongside low T), enclomiphene stimulates endogenous testosterone production without suppressing the HPG axis. If the secondary hypogonadism is driven by lifestyle factors (sleep deprivation, stress, obesity), enclomiphene or lifestyle optimization may restore testosterone and resolve cognitive symptoms without committing to lifelong exogenous TRT. Enclomiphene has less direct evidence on cognitive outcomes specifically, but testosterone restoration through any mechanism should produce comparable hormonal effects.

Should I see a neurologist or a TRT provider for brain fog?

The answer depends on your symptom profile. If brain fog is accompanied by physical low-T symptoms (reduced libido, muscle loss, fatigue, body fat gain) and lab-confirmed testosterone deficiency, a men's health or endocrinology specialist is the right starting point. If cognitive symptoms are progressive, affect multiple domains severely, involve memory loss beyond simple word retrieval, or are disproportionate to physical symptoms, a neurological evaluation is warranted — TRT is not a substitute for workup of potentially serious cognitive conditions.